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Cervical spondylotic myelopathy (CSM) is a common cause of adult spinal cord dysfunc-
tion. Although the therapeutic options for moderate to severe CSM patients have been es-
tablished well, the existing guidelines for therapeutic decisions in mild cases of CSM are 
unclear. We present a review of literature on conservative treatment and surgery for CSM 
and suggest general recommendations applicable in various clinical presentations and in 
different geographic locations across the globe, with due considerations to available re-
sources and locally prevalent practices.
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INTRODUCTION
Cervical spondylotic myelopathy (CSM) is generally a pro-
gressive disease with potentially dangerous consequences. How-
ever, the natural history of CSM is unpredictable in a given in-
dividual. This uncertainty is particularly a challenge in making 
right management decisions in persons with mild CSM (modi-
fied Japanese Orthopaedic Association [mJOA] score 15–17). 
There is also a subset of patients with magnetic resonance im-
aging (MRI) (done for unrelated or trivial reasons) suggesting 
of cord compression with or without cord signal changes. They 
may have coexistent radiculopathy. Typically, they present with 
mild symptoms without gross interference with activities of 
daily living, such as numbness in limbs, stiffness in lower limbs 
or urinary urgency. Neurological examination will be either 
normal or with minor abnormalities such as brisk deep tendon 
reflexes, extensor plantar response and positive Romberg’s sign.
The Spine Committee of the World Federation of Neurosur-
gical Societies (WFNS) formulated a consensus meeting on the 
management of CSM to develop recommendations for global 
applicability during Annual Conference of Neuro Spinal Sur-
geons Association, India at Nagpur in September 2018. Previ-
ously published guidelines1-3 were reviewed and complemented 
with review of the literature (PubMed) during the last 10 years 
to generate consensus recommendations.
MATERIALS AND METHODS
WFNS Spine Committee formulated a group of neuro-spinal 
surgeons to develop guidelines for treatment of CSM. The goal 
was to provide clinicians with evidence-based recommenda-
tions applicable across the globe for standardized care in patients 
with CSM. Each prioritized question was discussed using mod-
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The term degenerative cervical myelopathy (DCM) describes 
myelopathy resulting from cervical degenerative disc disease, 
ossification of the posterior longitudinal ligament (OPLL) or a 
combination of both. However, since it was a common term 
used for many years, the consensus was to use the term cervical 
spondylotic myelopathy instead of degenerative cervical my-
elopathy. OPLL which is commonly associated with cervical 
spondylotic changes in many Asian countries will not be men-
tioned separately.
The presenting features of CSM may be any one or a combi-
nation of the following 3 features: (1) myelopathy, (2) radicu-
lopathy, (3) cord compression in MRI. A patient with severe 
cord compression but no signs or symptoms may suddenly wor-
sen after a trivial fall during the period of conservative manage-
ment or they may develop significant complications if operated 
upon.
WFNS Spine Committee considered following observations 
and challenges while formulating recommendations applicable 
across the globe:
(1)  The heterogeneity of population worldwide with differ-
ences in knowledge and attitude regarding symptoms and 
signs of DCM. Cultural and socioeconomic factors have 
varied influence on patient’s perception of disease and ex-
pectation on outcome of interventions.
(2)  The differences in surgical preferences and practices in 
various regions.
(3)  Variations in reported outcome measures in DCM.
The relevant questions explored are as follows:
(1) When is a surgical treatment recommended for CSM?
(2)  When is a conservative (nonsurgical) treatment recom-
mended for CSM?
(3)  Is there a role of nonoperative treatment for patients with 
cord compression in imaging, but no clinical evidence of 
myelopathy?
(4)  What is the best management strategy for mild CSM- pre-
senting with myelopa-thy/radiculopathy/MRI changes?
(5)  What is the cost-effectiveness of surgery versus conserva-
tive treatment for mild CSM?
(6)  Does surgery for mild CSM result in minimally identifi-
able clinical difference?
Reported outcome themes vary widely as analyzed in system-
atic review by Davies et al.4 The themes include function (JOA, 
mJOA, Nurick score), complications, quality of life (Japanese 
Orthopedic Association Cervical Myelopathy Evaluation Ques-
tionnaire, Short Form 36 Health survey system), pain and im-
aging (X-ray, MRI). JOA, though widely accepted and incorpo-
rated in clinical studies, has practical challenges when applied 
in different cultures. Applying regional modifications would 
improve usability of mJOA.
Citations for systematic reviews, meta-analyses, reviews of 
clinical trials, evidence-based medicine, consensus development 
conferences, and guidelines were searched in PubMed Clinical 
Queries for Systematic Reviews with keywords as ‘cervical my-
elopathy.’ Reviews on nonoperative and conservative manage-
ment of DCM were identified and analyzed. Systematic reviews 
on ‘cervical myelopathy’ yielded 150 reviews. Six of the 150 sys-
tematic reviews were relevant for analyzing the role of nonop-
erative treatment.5-9
RESULTS AND DISCUSSION
Globally, CSM is very common with an estimated incidence 
of over 50% in population over 40 years of age. According to 
the Healthcare Cost and Utilization Project National US Inpa-
tient Sample database, 15,000–20,000 patients are hospitalized 
each year for surgical treatment of CSM at an annual cost of 
several hundred million dollars. Passias et al.10 in their analysis 
observed that there was increased number of surgeries in the 
last 10 years. While anterior cervical discectomy and fusion in-
creased by double fold, posterior alone by 4 fold, combined ap-
proach increased by 7 fold, thus increasing the economic bur-
den significantly. Unfortunately, it was also noticed that the over-
all morbidity also increased by 33.82%. The triggering costs as-
sociated with surgery and its complications represent an eco-
nomical burden, especially in developing countries. Therefore, 
the recommendations with a global outreach need to be cau-
tious and should consider evidence-based conclusions as well 
as its applicability according to local resources.
The Cochrane Database of Systematic Reviews by Nikolaidis 
et al.1 explored whether surgical treatment of cervical myelopa-
thy was associated with improved outcome compared to con-
servative treatment. Original review found only one study suit-
able for analysis after screening over 13,000 citations from 1966 
to 1998. Further revision of the review in 2010 added updated 
information of the same study by Kadanka et al.11 in 2002. The 
authors noted that mJOA and gait scores were better among 
conservatively managed patients at 6 months, but by 2 years no 
differences were noted between the 2 groups in terms of func-
tional disability. Though this study is very well designed, it lacks 
statistical power precluding any generalized guidelines.
Rhee et al.2 reviewed the role of nonoperative management of 
cervical myelopathy through a systematic search in PubMed 
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and the Cochrane Collaboration Library for articles published 
between 1956 and 2012. They included all articles that com-
pared nonoperative treatments or observation with surgery for 
patients with cervical myelopathy or asymptomatic cervical cord 
compression to determine their effects on clinical outcomes. 
Nonoperative treatments included physical therapy, medica-
tions, injections, orthoses, and traction. They noted a paucity of 
evidence regarding effectiveness of nonoperative treatment of 
cervical myelopathy. They suggested that, given the lack of evi-
dence and considering the generally progressive nature of cer-
vical myelopathy, nonoperative treatment cannot be routinely 
recommended.
A wide range (20%–60%) of patients will deteriorate neuro-
logically without surgical intervention with nonoperative treat-
ment (quality of evidence: moderate).12
In the largest prospective evaluation and the first global as-
sessment of surgical outcomes in patients with CSM, Fehlings 
et al.13 noted that surgery results in improved clinical outcomes, 
functional status and quality of life as evaluated by the modified 
Japanese Orthopedic Association Scale. Four hundred seventy-
nine symptomatic patients with image evidence of CSM were 
evaluated in this prospective, multicenter study from 16 global 
sites. The improvements after surgical decompression were sus-
tained between follow-up examinations at 1 year and 2 years 
after surgery. The study is particularly relevant in formulating a 
global consensus statement as there were significant regional 
differences in demographics, disease presentation and surgical 
preferences between various centers.
Cervical Spine Research Society (CSRS) developed with the 
help of a broad range of specialists analyzed systemic reviews in 
literature and with their clinical expertise formulated a multi-
disciplinary guideline and recommendations in the manage-
ment of CSM. These guidelines are endorsed by AOSpine North 
America. The details of the recommendations are summarized 
Table 1. Comparison of AOSpine North America and CSRS guidelines and WFNS Spine Committee Recommendations
Grade AOSpine North America and CSRS guidelines (2017) WFNS Spine Committee Recommendations (2019)
Moderate to severe CSM 
(mJOA score < 15)  
Recommend surgical intervention
Quality of evidence: moderate
Strength of recommendation: strong
Surgical intervention is recommended.
Mild CSM (mJOA score 
15–17)
Suggest offering surgical intervention or a supervised 
trial of structured rehabilitation for patients with mild 
DCM.
If initial nonoperative management is pursued, we rec-
ommend operative intervention if there is neurological 
deterioration and suggest operative intervention if the 
patient fails to improve.
Quality of evidence: very low to low
Strength of recommendation: weak
Suggest offering surgical intervention or rehabilitation 
for patients with mild CSM.
If at the beginning nonoperative management was fol-
lowed, we recommend operative intervention when 
rapid progression of symptoms appear.
Nonoperative management may be considered for 
slowly progressive disease.
Nonmyelopathic patients 
with evidence of cervical 
cord compression without 
signs or symptoms of  
radiculopathy
Suggest not offering prophylactic surgery.
Suggest that these patients be counselled as to potential 
risks of progression, educated about relevant signs and 
symptoms of myelopathy, and be followed clinically.
Quality of evidence: no identified evidence; based on clini-
cal expert opinion
Strength of recommendation: weak
Should not be offered a prophylactic surgery.
These patients should be counselled about the poten-
tial risk of worsening, educated about the signs and 
symptoms of progression and followed up regularly.
An informed consent should be obtained about neuro-
logical deficits that may follow trivial injury.
Nonmyelopathic patients 
with cord compression 
and clinical evidence of 
radiculopathy with or 
without electrophysiolog-
ical confirmation
Patients are at a higher risk of developing myelopathy 
and should be counselled about this risk.
Suggest offering either surgical intervention or nonoper-
ative treatment consisting of close serial follow-up or a 
supervised trial of structured rehabilitation.
In the event of myelopathic development, the patient 
should be managed according to the recommendations 
above.
Quality of evidence: low
Strength of recommendation: weak 
Patients are potential candidates who may deteriorate 
thus carrying high risk and hence need to be coun-
selled about it. These patients are recommended to 
undergo surgery or close observation with rehabilita-
tion if the patient refuses to undergo surgery.
In the event of developing myelopathic signs they are 
advised to go for surgery at the earliest.
An informed consent should be obtained about neuro-
logical deficits that may follow trivial injury.
CSRS, Cervical Spine Research Society; WFNS, World Federation of Neurosurgical Societies; DCM, degenerative cervical myelopathy; CSM, 
cervical spondylotic myelopathy; mJOA, modified Japanese Orthopaedic Association.
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in literature.3
These recommendations by the multidisciplinary guideline 
development group were noted to be relevant, credible and of 
good quality. It is recent enough (2017) and it has used the 
Grading of Recommendation, Assessment, Development and 
Evaluation (GRADE) approach. Based on these factors, it was 
decided to consider it as source guideline recommendation. 
While the recommendations of AOSpine North America and 
CSRS guided by Fehlings et al.3 were well done and accepted 
worldwide, a few additional points were added to meet global 
requirements. While quality of evidence and strength of recom-
mendation was clear in finalizing the recommendations in mod-
erate and severe CSM, they are not convincing in other grades 
in mild group and in cases with radiological evidence of cord 
compression with and without radiculopathy. We followed 
GRADE-ADOLOPMENT of guideline recommendations meth-
od14 to develop adapted recommendations. Prioritized ques-
tions matched with those of source guideline recommenda-
tions. Each prioritized question was discussed using modified 
Delphi method to establish consensus through voting.
WFNS SPINE COMMITTEE 
RECOMMENDATIONS
WFNS Spine Committee endorses the guidelines of Fehlings 
et al.3 The new and adapted WFNS Spine Committee Recom-
mendations after consensus are summarized below (Table 1):
(1)  For patients with moderate and severe CSM surgical in-
tervention is recommended. We recommend using mJOA 
or its regional modifications to classify CSM as severe, 
moderate or mild.
(2)  We suggest offering surgical intervention or rehabilitation 
for patients with mild CSM (mJOA score 15–17). If at the 
beginning nonoperative management was followed, we 
recommend operative intervention when rapid progres-
sion of symptoms appear. Nonoperative management may 
be considered for slowly progressive disease.
(3)  Nonmyelopathic patients with radiologic evidence of cord 
compression but without signs and symptoms of radicu-
lopathy should not be offered a prophylactic surgery. These 
patients should be counselled about the potential risk of 
worsening, educated about the signs and symptoms of 
progression and followed up clinically regularly. An in-
formed consent should be obtained about neurological 
deficits that may follow trivial injury.
(4)  Nonmyelopathic patients with radiologic evidence of cord 
compression and with clinical evidence of radiculopathy 
are potential candidates who may deteriorate thus carry-
ing high risk and hence need to be counselled about it. 
These patients are recommended to undergo surgery or 
close observation with rehabilitation if the patient refuses 
to undergo surgery. In the event of developing myelopath-
ic signs they are advised to go for surgery at the earliest. 
An informed consent should be obtained about neuro-
logical deficits that may follow trivial injury.
(5)  There is a consistent lack of evidence regarding the value 
of nonoperative treatment of cervical myelopathy in the 
literature. Hence nonoperative treatment may not be the 
final decision in most cases.
(6)  Predicting factors that indicate a possible deterioration 
during nonoperative management are: circumferential 
cord compression in axial MRI, reduced diameter of cere-
brospinal fluid space, hypermobility of spinal segment, 
angular edged deformity, instability, greater angle of ver-
tebral slip, lower segmental lordotic angle, and presence 
of OPLL.15,16
(7)  Important predictors of myelopathy development include 
the presence of symptomatic radiculopathy, prolonged 
motor evoked potentials and somatosensory evoked po-
tentials and electromyography signs of anterior horn cell 
lesions (low evidence).17
(8)  Duration of symptoms has a greater impact on outcomes. 
Substantial delay in surgical management leads to subop-
timal outcome.18,19 In other words, patients are likely to 
achieve a better result after surgery if they have a shorter 
duration of symptoms (low evidence).
(9)  As there is still clinical equipoise between surgery and 
conservative treatment in mild CSM, the WFNS Spine 
Committee strongly encourages randomized controlled 
trials comparing surgical versus nonsurgical interventions 
in mild CSM.20 There is also a need to analyze the cost-ef-
fectiveness, standardized methodology and costs of long-
term follow-up in mild CSM.21
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